Novo Holdings to Acquire Benchmark Genetics

Novo Holdings Acquires BBI Group

June 15, 2021

Medical Devices

Novo Holdings A/S has agreed to acquire BBI Group from Exponent for an enterprise value of over GBP 400 million, becoming the company's majority shareholder. BBI, a Crumlin, South Wales–headquartered supplier of diagnostics reagents, lateral flow development and diagnostic manufacturing services with more than 400 employees, will benefit from Novo Holdings' life-sciences expertise to pursue organic and inorganic growth.

Novo Holdings Acquires 25% Stake in Sejet Plant Breeding

June 27, 2024

Agriculture

Novo Holdings has agreed to acquire a 25% minority stake in Sejet Plant Breeding from DLG Group. The partnership will provide growth capital to scale Sejet’s plant-breeding operations and invest in new genomic and breeding technologies to accelerate development of climate-resilient crop varieties.

Novo Holdings Invests £50m in Oxford Nanopore Technologies

August 1, 2024

Biotechnology

Novo Holdings has invested £50 million in UK-listed Oxford Nanopore Technologies via an equity issue and intends to make further share purchases in the secondary market. The investment is intended to support Oxford Nanopore's commercial growth and capability expansion in biopharmaceutical and biomanufacturing markets.

Novo Holdings Leads $50M Growth Investment in MedGenome

August 30, 2022

Biotechnology

Novo Holdings led a $50 million minority investment in MedGenome alongside existing investors LeapFrog Investments and Sofina. The capital will support MedGenome’s expansion beyond South Asia into Africa and the Middle East and broaden access to its genomic testing, bioinformatics and research services.

Novo Holdings Acquires Ellab from EQT Private Equity

June 21, 2023

Medical Devices

Novo Holdings A/S has agreed to acquire Ellab from EQT Mid Market Europe (EQT Private Equity); the deal was announced in June and subsequently completed following regulatory approvals. Headquartered in Hillerød, Denmark, Ellab is a provider of validation and monitoring hardware, software and services for the biotech and pharmaceutical industries; the Lundbeck Foundation has also agreed to acquire a significant minority stake.

Novo Holdings Leads €7M Seed Investment in Bactolife

April 20, 2021

Biotechnology

Novo Holdings (via its Novo Seeds team) led a €7 million seed round in Danish biotech Bactolife, committing €5 million to advance the company's pipeline. The funding will support development and scaling of Bactolife's anti-virulence Virulence Inactivating Proteins (VIPs) for animal and human gut health; Novo's Aleks Engel will join Bactolife's board.